<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Transparency directive : regulatory news

02/04/2024 22:15



Other stories

30/04/2024 20:00
30/04/2024 19:45
30/04/2024 07:36
30/04/2024 15:02
30/04/2024 20:05
30/04/2024 10:37
30/04/2024 18:16
30/04/2024 14:24
30/04/2024 19:40
30/04/2024 10:52
30/04/2024 19:20
29/04/2024 20:19
30/04/2024 19:28
30/04/2024 09:09
30/04/2024 14:58
30/04/2024 20:22
30/04/2024 19:00
30/04/2024 16:51
30/04/2024 11:42
30/04/2024 08:01
30/04/2024 15:47
29/04/2024 16:39
30/04/2024 17:33
30/04/2024 00:12
30/04/2024 17:03
30/04/2024 10:28
30/04/2024 19:07
30/04/2024 20:06
30/04/2024 13:58
30/04/2024 17:18
30/04/2024 17:42
30/04/2024 11:43
29/04/2024 00:05
29/04/2024 12:00
30/04/2024 16:41
30/04/2024 14:21
30/04/2024 12:32
30/04/2024 06:56